{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:50:13Z","timestamp":1787590213302,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1053\/beha.2002.0182","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:24:48Z","timestamp":1027682688000},"page":"1-19","source":"Crossref","is-referenced-by-count":70,"title":["Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia"],"prefix":"10.1053","volume":"15","author":[{"given":"Dario","family":"Campana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Coustan-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2002.0182_RF1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","article-title":"Childhood acute lymphoblastic leukemia\u2014current status and future perspective","volume":"2","author":"Pui","year":"2001","journal-title":"Lancet Oncology"},{"key":"10.1053\/beha.2002.0182_RF2","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V90.7.2723","article-title":"In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia","volume":"90","author":"Kaspers","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199802193380803","article-title":"Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia","volume":"338","author":"Evans","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0182_RF4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2008-1026781","article-title":"[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]","volume":"199","author":"Riehm","year":"1987","journal-title":"Klinische Padiatrie"},{"key":"10.1053\/beha.2002.0182_RF5","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood.V86.4.1292.bloodjournal8641292","article-title":"Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia","volume":"86","author":"Gajjar","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2141.1997.1002914.x","article-title":"Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin","volume":"97","author":"Lilleyman","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0182_RF7","first-page":"2730","article-title":"Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows carly prediction of a favorable treatment outcome","volume":"92","author":"Schrappe","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"Dordelmann","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1996.14.2.389","article-title":"Cytoreduction and prognosis in acute lymphoblastic leukemia\u2014the importance of early marrow response: report from the Children's Cancer Group","volume":"14","author":"Steinherz","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0182_RF10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.leu.2402111","article-title":"International Childhood Acute Lymphoblastic Leukaemia Workshop: Sausalito, CA, 30 November\u20131 December 2000","volume":"15","author":"Pui","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.leu.2401780","article-title":"New definition of remission in childhood acute lymphoblastic leukemia","volume":"14","author":"Pui","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1470-2045(00)00418-6","article-title":"Minimal residual disease in leukaemia patients","volume":"2","author":"Szczepa\u0144ski","year":"2001","journal-title":"Lancet Oncology"},{"key":"10.1053\/beha.2002.0182_RF13","first-page":"33","article-title":"Subpopulations of normal and leukaemic human thymocytes: an analysis with the use of monoclonal antibodies","volume":"65","author":"Bradstock","year":"1980","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/beha.2002.0182_RF14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0145-2126(81)90002-3","article-title":"Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia","volume":"5","author":"Bradstock","year":"1981","journal-title":"Leukemia Research"},{"key":"10.1053\/beha.2002.0182_RF15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4049\/jimmunol.138.2.648","article-title":"The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage","volume":"138","author":"Campana","year":"1987","journal-title":"Journal of Immunology"},{"key":"10.1053\/beha.2002.0182_RF16","first-page":"47","article-title":"Detection of minimal residual disease in acute leukaemia by immunological marker analysis and polymerase chain reaction","volume":"6","author":"van Dongen","year":"1992","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.leu.2401741","article-title":"BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukaemia (T-ALL)","volume":"14","author":"Porwit-MacDonald","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1182\/blood.V56.3.430.430","article-title":"Cellular phenotypes of normal and leukemic hemopoietic cells determined by analysis with selected antibody combinations","volume":"56","author":"Janossy","year":"1980","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1309\/LXU4-Q7Q9-3YAB-4QE0","article-title":"Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukaemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features","volume":"114","author":"Rimsza","year":"2000","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2002.0182_RF20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00007890-198706000-00019","article-title":"Regeneration of TdT+, pre-B, and B cells in bone marrow after allogeneic bone marrow transplantation","volume":"43","author":"Asma","year":"1987","journal-title":"Transplantation"},{"key":"10.1053\/beha.2002.0182_RF21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood.V58.2.214.214","article-title":"Terminal deoxynucleotidyl transferase-containing cells in peripheral blood: implications for the surveillance of patients with lymphoblastic leukaemia or lymphoma in remission","volume":"58","author":"Froehlich","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF22","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1182\/blood.V89.8.2909","article-title":"Monoclonal antibodies specific to the acute lymphoblastic leukaemi at(1;19)-associated E2A\/pbx1 chimeric protein: characterization and diagnostic utility","volume":"89","author":"Sang","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood.V87.3.1123.bloodjournal8731123","volume":"87","author":"Smith","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.V87.3.1134.bloodjournal8731134","article-title":"Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7\u00b71, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements","volume":"87","author":"Behm","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF25","first-page":"2127","article-title":"Expression of the CEA gene family members NCA-50\/90 and NCA-160 (CD66) in childhood acute lymphoblastic leukemias (ALLs) and in cell lines of B-cell origin","volume":"8","author":"Hanenberg","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF26","first-page":"1233","article-title":"A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukaemia cells with high sensitivity","volume":"9","author":"Mori","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.leu.2401408","article-title":"The KOR-SA3544 antigen predominantly expressed on the surface of Philadelphia chromosome-positive acute lymphoblastic leukaemia cells is nonspecific cross-reacting antigen-50\/90 (CD66c) and invariably expressed in cytoplasm of human leukaemia cells","volume":"13","author":"Sugita","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002779900146","article-title":"CD66 expression in acute leukaemia","volume":"79","author":"Carrasco","year":"2000","journal-title":"Annals of Hematology"},{"key":"10.1053\/beha.2002.0182_RF29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.V72.1.299.299","article-title":"Asynchronous antigen expression in B lineage acute lymphoblastic leukemia","volume":"72","author":"Hurwitz","year":"1988","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H","article-title":"Detection of minimal residual disease in acute leukaemia by flow cytometry","volume":"38","author":"Campana","year":"1999","journal-title":"Cytometry"},{"key":"10.1053\/beha.2002.0182_RF31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.leu.2401279","article-title":"Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL","volume":"13","author":"Lucio","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.1999.01236.x","article-title":"Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL","volume":"104","author":"Ciudad","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0182_RF33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/10428190009087020","article-title":"Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukaemia by comparative phenotype mapping: method and significance","volume":"38","author":"Dworzak","year":"2000","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0182_RF34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cyto.990180404","article-title":"Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression","volume":"18","author":"Lavabre-Bertrand","year":"1994","journal-title":"Cytometry"},{"key":"10.1053\/beha.2002.0182_RF35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V79.4.1011.bloodjournal7941011","article-title":"Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukaemia is associated with chromosomal hyperdiploidy and other favorable prognostic features","volume":"79","author":"Behm","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF36","first-page":"305","article-title":"Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations","volume":"26","author":"Dworzak","year":"1998","journal-title":"Experimental Hematology"},{"key":"10.1053\/beha.2002.0182_RF37","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood.V97.7.2115","article-title":"Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia","volume":"97","author":"Chen","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF38","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1200\/JCO.2000.18.24.4067","article-title":"Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study","volume":"18","author":"Seeger","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0182_RF39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM200002243420801","article-title":"Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer","volume":"342","author":"Braun","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0182_RF40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/1097-0320(20001215)42:6<357::AID-CYTO1002>3.0.CO;2-6","article-title":"Quantitative analysis of disseminated tumor cells in the bone marrow by automated fluorescence image analysis","volume":"42","author":"Mehes","year":"2000","journal-title":"Cytometry"},{"key":"10.1053\/beha.2002.0182_RF41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2141.1997.3323151.x","article-title":"Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission","volume":"99","author":"Engel","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0182_RF42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1097-0320(19970215)30:1<47::AID-CYTO7>3.0.CO;2-C","article-title":"Sensitivity of combined DNA\/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukaemia cells in bone marrow","volume":"30","author":"Nowak","year":"1997","journal-title":"Cytometry"},{"key":"10.1053\/beha.2002.0182_RF43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","article-title":"Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia","volume":"351","author":"Coustan-Smith","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0182_RF44","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.leu.2402150","volume":"15","author":"Lucio","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/cyto.990140511","article-title":"Detection of rare cells at a frequency of one per million by flow cytometry","volume":"14","author":"Gross","year":"1993","journal-title":"Cytometry"},{"key":"10.1053\/beha.2002.0182_RF46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1073\/pnas.92.2.537","article-title":"Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(\u22127)","volume":"92","author":"Gross","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2002.0182_RF47","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.leu.2401459","article-title":"Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"13","author":"Neale","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF48","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/sj.leu.2401219","article-title":"Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias","volume":"12","author":"Wells","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0022-1759(84)90373-9","article-title":"Improved detection of rare CALLA-positive cells in peripheral blood using multiparameter flow cytometry","volume":"74","author":"Ryan","year":"1984","journal-title":"Journal of Immunological Methods"},{"key":"10.1053\/beha.2002.0182_RF50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cyto.990220408","article-title":"Use of fluorescence threshold triggering and high-speed flow cytometry for rare event detection","volume":"22","author":"Rehse","year":"1995","journal-title":"Cytometry"},{"key":"10.1053\/beha.2002.0182_RF51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L","article-title":"Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis)","volume":"27","author":"Darzynkiewicz","year":"1997","journal-title":"Cytometry"},{"key":"10.1053\/beha.2002.0182_RF52","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1182\/blood.V64.3.701.701","article-title":"Lineage switch in acute leukemia","volume":"64","author":"Stass","year":"1984","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF53","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1182\/blood.V74.6.2088.2088","article-title":"Molecular heterogeneity in acute leukaemia lineage switch","volume":"74","author":"Gagnon","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF54","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood.V83.8.2238.2238","article-title":"Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis","volume":"83","author":"Beishuizen","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood.V54.1.64.64","article-title":"Shifts in expression of cell membrane phenotypes in childhood lymphoid malignancies at relapse","volume":"54","author":"Borella","year":"1979","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0145-2126(80)90043-0","article-title":"Acute lymphoblastic leukaemia associated antigen. III ALterations in expression during treatment and in relapse","volume":"4","author":"Greaves","year":"1980","journal-title":"Leukemia Research"},{"key":"10.1053\/beha.2002.0182_RF57","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood.V78.5.1327.1327","article-title":"Characterization of childhood acute leukaemia with multiple myeloid and lymphoid markers at diagnosis and at relapse","volume":"78","author":"Pui","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF58","first-page":"357","article-title":"Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukaemia at diagnosis and relapse: a Pediatric Oncology Group study","volume":"6","author":"Abshire","year":"1992","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF59","first-page":"1523","article-title":"Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia","volume":"9","author":"van Wering","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/blood.V76.1.163.163","article-title":"The immunologic detection of minimal residual disease in acute leukemia","volume":"76","author":"Campana","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF61","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/cyto.990130813","article-title":"Flow cytometric determination of atypical antigen expression in acute leukaemia for the study of minimal residual disease","volume":"13","author":"Drach","year":"1992","journal-title":"Cytometry"},{"key":"10.1053\/beha.2002.0182_RF62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000157129","article-title":"Flow cytometric analysis of normal B lymphoid development","volume":"7","author":"Loken","year":"1988","journal-title":"Pathology and Immunopathology Research"},{"key":"10.1053\/beha.2002.0182_RF63","first-page":"609","article-title":"The detection of residual acute lymphoblastic leukaemia cells with immunologic methods and polymerase chain reaction: a comparative study","volume":"4","author":"Campana","year":"1990","journal-title":"Leukaemia"},{"key":"10.1053\/beha.2002.0182_RF64","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood.V96.8.2691","article-title":"Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"96","author":"Coustan-Smith","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF65","article-title":"Prognostic significance of measuring early clearance of leukaemic cells by flow cytometry in childhood acute lymphoblastic leukemia","author":"Coustan-Smith","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF66","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1200\/JCO.1997.15.3.1150","article-title":"TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance","volume":"15","author":"Rubnitz","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0182_RF67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.leu.2401257","article-title":"Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup","volume":"13","author":"Rubnitz","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0182_RF68","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2141.1982.tb03908.x","article-title":"Cytogenetics of acute lymphoblastic leukaemia in children as a factor in the prediction of long-term survival","volume":"52","author":"Secker-Walker","year":"1982","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0182_RF69","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1182\/blood.V60.4.864.864","article-title":"Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia","volume":"60","author":"Williams","year":"1982","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0182_RF70","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1200\/JCO.1992.10.4.606","article-title":"Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukaemia of childhood: a Pediatric Oncology Group study","volume":"10","author":"Trueworthy","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0182_RF71","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Drug therapy: acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0182_RF72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0182_RF73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2141.1998.00675.x","article-title":"Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry","volume":"10","author":"Farahat","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0182_RF74","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1200\/JCO.1998.16.12.3774","article-title":"Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia","volume":"16","author":"Ciudad","year":"1998","journal-title":"Journal of Clinical Oncology"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602901829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602901829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:09:43Z","timestamp":1682140183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692602901829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S1521692602901829"],"URL":"https:\/\/doi.org\/10.1053\/beha.2002.0182","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}